Search companies

Live

Tuesday, 17 November 2026 · 586 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Tribeca Lifts Integral Diagnostics Stake Above 6% as CEO Adds Shares

IDX: $1.76 -0.28% · MC: $622M

Tribeca Investment Partners’ reported voting power in Integral Diagnostics rose from 5.03% to 6.04%, while CEO Jason Martinez acquired additional shares on market, increasing his direct holding from 30,000 to 45,000 shares. The substantial-holder notice lists on-market purchases and sales since its previous filing, but the supplied excerpt does not include the full transaction schedule.

Source announcements: 2026-11-02 12:28 to 2026-11-02 17:33 Sydney time
Story updated 2026-11-02 17:37 Sydney time
SourcesChange of Director's Interest Notice - Jason Martinez CEOChange in substantial holding
Comments